Head of Translational Sciences and Preclinical Pharmacology

South San Francisco, California, United States


Surrozen is an innovative biopharmaceutical startup founded by Drs. Chris Garcia, Roel Nusse, Calvin Kuo and Claudia Janda, world-leading scientists from Stanford University. The company is focused on harnessing the Wnt pathway to identify novel therapeutics for regenerative medicine, leveraging our founders breakthrough insights in protein engineering, stem cell dynamics, and fundamental Wnt biology. Funded by The Column Group, a leading biotech venture capital firm, Surrozen is poised for robust growth and offers a stimulating work environment, competitive compensation and benefits, and an attractive relocation program.

Surrozen is seeking a Head of Translational Sciences and Preclinical Pharmacology who is a highly experienced large molecule drug discovery professional with an outstanding track record. This position is responsible for planning and implementing all non-clinical studies including drug exposure, efficacy and toxicology studies across species. This position will work collaboratively with internal cross-functional teams and with consultants or potential external resources to plan and execute an overall development strategy for candidate molecules progressing from discovery research to clinical development. A background in regenerative medicine is highly desirable and a proven ability to deliver large molecule therapeutics into the clinic is essential.

Key Responsibilities:



Apply for this job